Rein Therapeutics RNTX
NASDAQ RNTX
$0.58 -0.02 (-3.37%)
At close: Oct 23, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Return on Sales [ROS] (2016)

Updated

Analysis

Rein Therapeutics (RNTX) Return on Sales [ROS] (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Rein Therapeutics 39.26 Mn -4.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -129,778.57%
Mar 31, 2016 -28,135.71%
API Access

Rein Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RNTX&period=max&api_key=YOUR_API_KEY